300294.SZ · 博雅生物
China A-shares · RS rating 30 · As of 2026-10-14
| Price | 14.39 CNY |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 72 / 51 / 11 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 17 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +0.4% |
| Distance from 52-week high | +43.5% |
| Market cap (USD) | $1.1B |